Lipertance

Amlodipine besilate / Perindopril arginine / Atorvastatin calcium trihydrate, the active ingredients in Lipertance, constitute a calcium channel blocker, an ACE inhibitor and an HMG‑CoA reductase inhibitor presented as an oral tablet for systemic use. It works by simultaneously lowering blood pressure and cholesterol levels, providing a convenient single‑pill approach for patients requiring multiple therapies.

GNH USA supplies Lipertance as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lipertance combines agents that act on blood pressure regulation and lipid metabolism, and is used for the following clinical indications: - Hypertension: lowers systolic and diastolic blood pressure, helping achieve target levels. - Hyperlipidaemia: reduces LDL‑cholesterol and total cholesterol, supporting lipid control. - Cardiovascular risk reduction: decreases the likelihood of major adverse cardiovascular events in patients with multiple risk factors.

Lipertance may cause a range of adverse reactions. The most frequently reported events are generally mild and reversible.

Common Side Effects: - Headache: mild to moderate intensity. - Peripheral edema: swelling of ankles or lower legs. - Cough: dry, persistent throat irritation. - Dizziness or light‑headedness. - Muscle pain or weakness. - Gastrointestinal upset: nausea, abdominal discomfort.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips, tongue, or airway. - Severe liver injury: jaundice, elevated transaminases. - Rhabdomyolysis: muscle breakdown with dark urine. - Significant hypotension: marked drop in blood pressure. - Pancreatitis: abdominal pain with elevated enzymes. - Anaphylactic reaction: severe allergic response requiring emergency care.

Before initiating Lipertance, clinicians should consider several safety aspects. - Blood pressure monitoring: obtain baseline readings and reassess after dose changes. - Renal function: evaluate creatinine and eGFR, especially in patients with chronic kidney disease. - Hepatic enzymes: monitor liver function tests due to the statin component. - Electrolyte balance: watch potassium and sodium levels when combined with diuretics. - Pregnancy and lactation: prescribe only if potential benefits outweigh risks. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Lipertance interacts with several drug classes; awareness of major and moderate interactions helps avoid adverse outcomes.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., itraconazole): increase atorvastatin exposure. - Concomitant ACE inhibitors or ARBs: risk excessive hypotension and renal impairment. - Fibrates such as gemfibrozil: heightened risk of myopathy. - Aliskiren in diabetic patients: contraindicated due to renal risk. - Lithium: may raise lithium serum concentrations.

Moderate Interactions (Monitor Closely): - NSAIDs: may blunt antihypertensive effect. - Diuretics: can potentiate hypotension and electrolyte shifts. - Antacids containing aluminum/magnesium: may affect amlodipine absorption. - Beta‑blockers: additive blood pressure lowering. - Grapefruit juice: may increase amlodipine plasma levels.